IUHSA
CHRS icon

Itau Unibanco Holding S.A.’s Coherus Oncology CHRS Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-989
Closed -$22K – 898
2019
Q3 		$22K Hold
989
– – ﹤0.01% 262
2019
Q2 		$22K Sell
989
-1,984
-67% -$34.5K ﹤0.01% 570
2019
Q1 		$26K Hold
2,973
– – ﹤0.01% 554
2018
Q4 		$26K Sell
2,973
-3
-0.1% -$35 ﹤0.01% 554
2018
Q3 		$49K Sell
2,976
-83
-3% -$1.47K ﹤0.01% 545
2018
Q2 		$43K Sell
3,059
-849
-22% -$12.2K ﹤0.01% 630
2018
Q1 		$43K Buy
3,908
+2,771
+244% +$30.3K ﹤0.01% 491
2017
Q4 		$10K Buy
1,137
+142
+14% +$1.52K ﹤0.01% 522
2017
Q3 		$42K Buy
+995
New +$13.2K ﹤0.01% 597

Other funds holding CHRS

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Itau Unibanco Holding S.A.'s CHRS Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Coherus Oncology (CHRS) in Q4 2019, closing a stake of 989 shares — an estimated $22K sold.

Itau Unibanco Holding S.A. first reported a position in CHRS in Q3 2017 and held it in 9 quarters. The position peaked at $49K in Q3 2018. 188 funds tracked by Wall St. Rank hold CHRS as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Coherus Oncology position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 989 Coherus Oncology shares in Q4 2019, an estimated $22K.
  • Itau Unibanco Holding S.A. first reported a position in Coherus Oncology in Q3 2017 and held it in 9 quarters.
  • Itau Unibanco Holding S.A.'s Coherus Oncology position peaked at $49K in Q3 2018.
  • 188 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.